Eve Holding Inc
For the period ended Sep 30, 2024. Filed Nov 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 4, 2024
EVEX$1.99+2.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)(Unaudited)
| · · Nine Months Ended September 30, | |||
|---|---|---|---|
| | | 2024 | 2023 |
| Cash flows from operating activities | |||
| Net loss | $(97,472) | $(88,392) | |
| Adjustments to reconcile net loss to net cash used by operating activities | |||
| Depreciation and amortization | 176 | 143 | |
| Non-cash lease expenses | 366 | 55 | |
| Unrealized gain on the exchange rate changes | (1,220) | (385) | |
| Share-based compensation | 2,770 | 3,320 | |
| Warrant expenses | - | 480 | |
| Change in fair value of derivative financial instruments | (12,398) | 9,833 | |
| Changes in operating assets and liabilities | |||
| Accrued interest on financial investments, net | (5,040) | (5,667) | |
| Accrued interest on related party loan receivable, net | 2,042 | 844 | |
| Other assets | (1,499) | (733) | |
| Related party receivables | 163 | (1,898) | |
| Accounts payable | (569) | (257) | |
| Related party payables | 11,515 | 8,016 | |
| Other payables | 3,874 | 4,644 | |
| Net cash used by operating activities | (97,290) | (69,997) | |
| Cash flows from investing activities | |||
| Redemptions of financial investments | 60,000 | 72,500 | |
| Purchases of financial investments | (199,000) | (52,500) | |
| Collection of related party loan | 81,000 | - | |
| Expenditures for property, plant and equipment | (4,001) | (168) | |
| Net cash (used) provided by investing activities | (62,001) | 19,832 | |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock, net of fees to investors | 94,288 | - | |
| Non-investor equity issuance costs | (981) | - | |
| Proceeds from debt, net | 45,246 | 11,375 | |
| Non-creditor debt issuance costs | (787) | (375) | |
| Tax withholding on share-based compensation | - | (287) | |
| Proceeds from exercised warrants | 9 | 1 | |
| Net cash provided by financing activities | 137,774 | 10,714 | |
| Effect of exchange rate changes on cash and cash equivalents | (792) | 402 | |
| Decrease in cash and cash equivalents | (22,310) | (39,049) | |
| Cash and cash equivalents at the beginning of the period | 46,882 | 49,146 | |
| Cash and cash equivalents at the end of the period | $24,572 | $10,097 | |
| Supplemental disclosure of cash information | |||
| Cash paid for | |||
| Income tax | $2,762 | $875 | |
| Interest | $1,317 | $ | - |
| Supplemental disclosure of other non-cash investing and financing activities | |||
| Property, plant & equipment expenditures in accounts payable and other accruals | $41 | $ | - |
| Right-of-use assets obtained in exchange for operating lease liabilities | $1,118 | $373 | |
| Issuance of common stock for vested restricted stock units | $878 | $1,366 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.